Matinas BioPharma to Present Company Replace and 2023 Enterprise Outlook on January 30, 2023
Matinas BioPharma Holdings, Inc. Convention name and dwell audio webcast scheduled for Monday, January thirtieth at 4:30 p.m. ET BEDMINSTER, N.J., Jan. 23, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE AMER: MTNB), a clinical-stage biopharmaceutical firm centered on redefining the intracellular supply of nucleic acids and small molecules with its lipid nanocrystal (LNC) platform expertise, at […]
AGF Administration Restricted to Launch Fiscal 2022 Outcomes on January 25, 2023
Article content material TORONTO, Jan. 05, 2023 (GLOBE NEWSWIRE) — AGF Administration Restricted (TSX: AGF.B) will launch its monetary outcomes for fiscal 2022 on Wednesday,...